Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The Kokomo woman was pre-diabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

Semaglutide has been around for over 20 years ... your weight isn’t budging, or your A1c is still climbing. You could be a good candidate if you can’t lose weight despite putting in the ...

PAK vs WI: Pakistan and West Indies are set to clash in their last Test series of the World Test Championship 2025 cycle in Multan starting on January 17. Both teams enter this two-match series ...

GetSimpli Oral Semaglutide offers a promising solution for those looking to enhance their overall well-being, manage their weight, and improve metabolic health. As an innovative sublingual tablet ...

"The landmark 10-year, 1,440-person Diabetes Control and Complications Trial (DCCT), published in 1993, established hemoglobin A1c as the gold standard for evaluating the risk for complications ...

Semaglutide resulted in more patients reaching A1c target of <7%, and significantly more average weightloss, than liraglutide once daily. LA GLP1-RAs have shown at least equal reduction in weight ...